India has imposed anti-dumping responsibility on import of Chinese language pharma product, used within the therapy of sure infections, to guard home producers from below-cost shipments.
The responsibility on import of ‘Ofloxacin’ from China will probably be within the vary of $2.58 to $9.48 per kg for 3 years, mentioned a notification issued by the Income Division within the Finance Ministry.
The levy has been slapped following the suggestions of the Directorate Basic of Anti-Dumping and Allied Duties (DGAD).
Aarti Medicine had approached DGAD for initiation of anti-dumping investigation and imposition of responsibility on Ofloxacin imports. After a probe into the imports, the Authority concluded that the product has been exported to India from China beneath its regular worth, “leading to dumping’’.
“The home business has suffered materials harm as a result of dumping of the product…,” the DGAD mentioned whereas recommending the levy.
Ofloxacin is used to deal with sure infections, together with bronchitis, pneumonia and infections of the pores and skin, bladder, urinary tract, reproductive organs, and prostate (a male reproductive gland).
International locations perform anti-dumping probe to find out whether or not their home industries have been harm due to a surge in imports that are beneath the price of producing them. As a counter measure, they impose duties below the multilateral regime of WTO.
The responsibility is geared toward making certain honest buying and selling practices and making a level-playing subject for home producers with regard to international producers and exporters.